REGISTER NOW! Webinar: Your Trial Post-COVID: Recovery Must Start Now, Friday, 29 May 2020

21 May 2020

Cromos Pharma, in association with MKR Clinical Research Consultants, presents a webinar: 

Your Trial Post-COVID: Recovery Must Start Now 

Friday, 29 May 2020

(9am PST, 12pm EST, 6pm CET)

REGISTER NOW

Join our experts for a forward-looking webinar focused on getting your clinical trials back on track as many countries begin to lift COVID-19 pandemic restrictions. By using scenario-based modelling our team has developed a comprehensive roadmap for restarting clinical trials as we move into a new phase of dealing with the pandemic.

Webinar Overview

The COVID-19 pandemic has had a significant impact on the clinical trial industry with many trials halted, others postponed while for those ongoing there has been a shift to remote and virtual communications with trial sites. There is growing recognition that we will be dealing with this pandemic for some time and that its effects will be far reaching, changing the ways in which clinical research has been traditionally conducted. In the light of this, it is imperative that we consider what actions are needed to resume clinical trials amid these new conditions. 

Cromos Pharma has approached this challenging task by taking an ongoing international trial and subjecting it to extensive risk assessment and scenario-based modeling. The trial metrics were analysed based on different actions, from waiting for the return of business as usual to the most aggressive rescue measures available. 

After studying the outcomes our expert team has come up with a comprehensive roadmap to navigate the “new normal” and get clinical trials up and running in the most effective and efficient manner possible.

Join us to see the range of actions required to ensure preparedness for restarting clinical trials as the pandemic enters a more controlled phase. Register now!

 Speakers 

Vlad.png 

 

Vlad Bogin, MD, FACP 

CEO & Founder @Cromos Pharma

Dr. Bogin started his medical training at Moscow Medical Academy, then trained at Yale and Brown Universities and received his postgraduate training at the University of Rochester where he was also elected to a chief medical resident position. Dr. Bogin has been involved in the drug development cycle for over 15 years, from basic discovery research to clinical trial design and execution. As a director at Boehringer Ingelheim he was in charge of late stage development of a leading cardiology product. As the Chairman of the Board at Medistem Inc., Dr. Bogin was instrumental in advancing the company from the preclinical to clinical stage, from a non-reporting to a fully reporting publicly trading company, and for a subsequent successful liquidity event in early 2014. Dr. Bogin maintains active medical license and hospital privileges and is an advisor to numerous companies and non-profit organizations. Dr. Bogin is an author of numerous peer-reviewed articles, book chapters and patents. 

Steph.png   

Stephanie Finnegan, MBA 

COO @Cromos Pharma 

Stephanie Finnegan is the Chief Operating Officer of Cromos Pharma, and is responsible for global operations, spanning North America, Europe, and Asia. She has thirty years of experience in pharmaceutical drug development, ranging from M&A and portfolio management to biomanufacturing and clinical research. She founded the biotech industry’s first contract manufacturer specializing strictly in recombinant proteins and monoclonal antibodies. For the past fifteen years, she has been working as a leader in CRO organizations, using her broad experience to specialize in biologics, biosimilars, and oncology/immunology. Stephanie has a BS in mathematics and an MBA/CPA.

Photo.png 

Jason Rubine, MSH 

Director of Clinical Operations @MKR Clinical Research Consultants

Jason Rubine is a clinical research professional with 15+ years of industry experience at the Sponsor and CRO levels across numerous therapeutic areas. With his combined scientific and research knowledge, he understands the most intricate details of the research industry in order to bring the clinical trials to success. Mr. Rubine heads up a geographically dispersed team and contributes heavily toward MKRs operational excellence. In addition, Mr. Rubine provides a lead role in client management, working with client managers and vendors within the industry to meet their needs for staffing solutions. Jason has a bachelor’s degree in Nutritional Science from The Pennsylvania State University and a master’s degree in Nutritional Science from The University of North Florida.  

Vladimir.png   

Vladimir Krechikov, MD, PhD 

Head of Region, Eastern Europe @Cromos Pharma

Dr Vladimir Krechikov started his career in clinical research as an investigator, then worked at various positions in clinical operations of global CROs before transitioning to a Director of Business Development position at one of the largest regional CROs. More than 10 years ago, Dr. Krechikov moved to Cromos Pharma, where he held various positions in Business Development and is now Head of Region, Eastern Europe. He graduated from Smolensk State Medical Academy (Russia) as a medical doctor, then received his postgraduate training at Queen Mary University of London (UK) and received PhD in clinical pharmacology. He is an author of more than 30 scientific publications in peer-reviewed journals.

Zsolt.png   

Zsolt Kocsis, MD, MBA

Country Head, Hungary @Cromos Pharma

Zsolt Kocsis is a clinical research professional with 12+ years of industry experience at sponsor and CRO levels across numerous therapeutic areas. Dr. Kocsis heads the Hungarian Office of Cromos Pharma and contributes to Cromos Pharma’s Central European operations. Zsolt holds a medical degree (MD) and a business degree (MBA). 

 

 

 

Back to the news